TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling
Wanlei Yang(Zhejiang Chinese Medical University), Yu Qian(Zhejiang Chinese Medical University)
Cited by 52
Related Papers
Galangin suppresses human osteosarcoma cells: An exploration of its underlying mechanism
|Oncology Reports|2016|33
<p>Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo</p>
|Drug Design Development and Therapy|2020|23
Dual protective role of velutin against articular cartilage degeneration and subchondral bone loss via the p38 signaling pathway in murine osteoarthritis
|Frontiers in Endocrinology|2022|10
<p>Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo</p>
|Drug Design Development and Therapy|2020|5